Twist Bioscience Launches Custom MRD Panels for Cancer Assay Development
The new platform offers custom panel manufacturing in as little as one day to support development of tumor-informed MRD assays.
Latest Articles
Editor's Top Picks
FDA Clears Sekisui Diagnostics Rapid COVID-19 and Flu A&B Combo Test
The CLIA-waived test detects and differentiates SARS-CoV-2, influenza A, and influenza B from a single nasal swab for point-of-care use.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Ozelle to Showcase AI-Assisted Hematology Analyzer at MEDICA 2026
The O-Cyte 1 combines complete blood count testing, seven-part white blood cell differentials, and digital cell imaging, with configurations supporting up to 360 tests per hour.
Equipment & Supply Spotlight
Hologic and Inpeco Partner to Connect Panther Systems with FlexLab X Automation in Europe
The partnership will allow clinical laboratories to integrate multiple Panther Systems into automated workflows designed to increase testing capacity and improve sample tracking.
News, Know-How & Standards
Disease Detection & Understanding
Hologic to Acquire Reveal Genomics to Expand Breast Cancer Genomic Testing Portfolio
Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its oncology diagnostics portfolio and expanding genomic testing options for breast cancer, according to a company statement.
